review · 2013
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban
The new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynami...
72 citationsDOI: https://doi.org/10.3949/ccjm.80a.13025Open accessPDF reported by metadataFull text reported by metadata